Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a TH1 response

被引:16
作者
Wittmann, M [1 ]
Alter, M [1 ]
Stünkel, T [1 ]
Kapp, A [1 ]
Werfel, T [1 ]
机构
[1] Hannover Med Univ, Dept Dermatol & Allergol, D-30449 Hannover, Germany
关键词
monocytes/macrophages; T-lymphocytes; skin; transcription factors; human;
D O I
10.1016/j.jaci.2004.06.033
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The production of IL-12 by monocytes and dendritic cells is tightly regulated and critically dependent on signals from surrounding cells in the micromilieu. Objective: We studied the capacity of T cells to regulate directly the production of IL-12 by human monocytes. Methods: Human isolated CD4(+) T cells from peripheral blood and T cells from acute patch test lesions were cocultured with autologous monocytes. IL-12 expression and production were measured, and intracellular signal transduction pathways were studied. Monocytes, which had been cocultured with activated T cells, were further investigated for their capacity to induce T(H)1-directed responses. Results: A marked inhibition of IL-12 production was observable on coculture of monocytes with isolated CD4(+) activated autologous T lymphocytes derived from blood or from acute eczematous skin lesions. The inhibiting effect of activated T lymphocytes on IL-12 production was dependent on cell-to-cell contact to monocytes but not on their ability to secrete soluble mediators. Experiments performed in the presence of mitogen-activated protein kinase kinase 1/2 inhibitors provided evidence that activation of the p44/42 pathway plays an important role for the inhibition of IL-12 production in monocytes (here referred to as IL-12(low) monocytes). In addition, T cells cocultured with IL-12(low) monocytes showed a markedly lower expression of the T(H)1 specific transcription factor T-bet, IFN-gamma, and IL-12Rbeta2 cell surface expression. Conclusion: Activated T lymphocytes may directly contribute to the T(H)2-like cytokine milieu found at sites of allergic inflammation (eg, in acute eczematous skin lesions) by inhibiting IL-12 production of unprimed antigen-presenting cells.
引用
收藏
页码:965 / 973
页数:9
相关论文
共 37 条
[11]   Inhibition of interferon γ induced interleukin 12 production:: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor [J].
Hodge-Dufour, J ;
Marino, MW ;
Horton, MR ;
Jungbluth, A ;
Burdick, RD ;
Strieter, RM ;
Noble, PW ;
Hunter, CA ;
Puré, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13806-13811
[12]  
Josien R, 1999, J IMMUNOL, V162, P2562
[13]  
Karp CL, 1998, EUR J IMMUNOL, V28, P3128, DOI 10.1002/(SICI)1521-4141(199810)28:10<3128::AID-IMMU3128>3.0.CO
[14]  
2-T
[15]   The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells [J].
Ma, XJ ;
Chow, JM ;
Gri, G ;
Carra, G ;
Gerosa, F ;
Wolf, SE ;
Dzialo, R ;
Trinchieri, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :147-157
[16]   Role of T-bet in commitment of TH1 cells before IL-12-dependent selection [J].
Mullen, AC ;
High, FA ;
Hutchins, AS ;
Lee, HW ;
Villarino, AV ;
Livingston, DM ;
Kung, AL ;
Cereb, N ;
Yao, TP ;
Yang, SY ;
Reiner, SL .
SCIENCE, 2001, 292 (5523) :1907-1910
[17]   CD40 and its ligand in host defense [J].
Noelle, RJ .
IMMUNITY, 1996, 4 (05) :415-419
[18]   Accessory signaling by CD40 for T cell activation: Induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production [J].
Peng, XH ;
Kasran, A ;
Warmerdam, PAM ;
deBoer, M ;
Ceuppens, JL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) :1621-1627
[19]   A new mathematical model for relative quantification in real-time RT-PCR [J].
Pfaffl, MW .
NUCLEIC ACIDS RESEARCH, 2001, 29 (09) :E45
[20]   Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: Evidence of functional synergy between C/EBP and Rel proteins [J].
Plevy, SE ;
Gemberling, JHM ;
Hsu, S ;
Dorner, AJ ;
Smale, ST .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) :4572-4588